甲钴胺治疗糖尿病末梢神经病变的疗效观察及护理干预

以综合性护理干预，可有效提升患者医疗满意度，改善患者生活质量。
[关键词] 甲钴胺；糖尿病；末梢神经病变；护理干预；护理效果
[中图分类号] R587.2; R473.5
[文献标识码] A
[文章编号] 1672-2809(2019)20-0078-02
Clinical Observation and Nursing Intervention of Mecobalamin in the Treatment of Diabetic Peripheral Neuropathy
随着我国老年人口基数的增加，以糖尿病为首的中老 年慢性疾病发病率不断上，严重威胁患者身心健康。由于 糖尿病治疗周期长，加之患者机体免疫功能下降，其并发 症发生率也在不断上升，其中以糖尿病神经病变较为严 重，具有较高的致残率和致死率[1]。末梢神经病变在糖尿 病合并症症状中发生较早，主要以下肢沉重为主要表现， 伴有感觉障碍，对治疗要求及时性，于急性期给予治疗干 预预后较好，若没有及时给予患者治疗及护理干预，极易导 致不良预后出现，降低患者生活质量[2]。为此选取58例糖尿 病末梢神经病变患者作为观察对象，旨在观察甲钴胺治疗 糖尿病末梢神经病变的疗效观察及护理干预，报道如下。 1 资料与方法 1.1 一般资料 选取2018年2月至2019年2月于我院住院部 接受治疗的58例糖尿病末梢神经病变患者作为观察对象， 本研究经院伦理会批准开展，采用随机数表法进行分组对 照，其中对照组患者共29例，男性16例，女性13例，年龄 39～75岁，平均年龄(49.62±1.62)岁，糖尿病病史在10个 月～13年，平均病史时间为(5.81±1.16)年；研究组患者 共29例，男性15例，女性14例，年龄40～76岁，平均年龄 (50.08±1.84)岁，糖尿病病史在11个月～13年，平均病史 时间为(5.69±1.23)年。对两组患者一般资料数据做客观分 析(P>0.05)。
组患者总有效率（９６．５５％）明显高于对照组（７９．３１％），有统计学差异（P＜０．０５）。护理干预前，两组患者的临床症状积分无明显差异（P＞０．０５）；
护理干预后，研究组患者的临床症状积分明显低于对照组（P＜０．０５）；研究组的护理技能评分、人文关怀评分、护理态度评分均高于对照组
（P＜０．０５）；研究组患者的并发症发生率明显低于对照组（P＜０．０５）。结论：甲钴胺治疗糖尿病末梢神经病变可有效改善患者临床症状，同时辅
QIU Jin-yu
Xinfeng People’s Hospital, Ganzhou Jiangxi 341600, China [Abstract] Objective: To investigate the effect of mecobalamin on diabetic peripheral neuropathy and its nursing intervention. Methods: 58 patients with diabetic peripheral neuropathy were randomly divided into two groups. All patients were treated with Mecobalamin. The control group was given routine nursing intervention. The study group was given comprehensive nursing intervention. The curative effect and nursing effect of the two groups were compared. Results: the total effective rate of the study group (96.55%) was significantly higher than that of the control group (79.31%) (P<0.05). Before nursing intervention, there was no significant difference in clinical symptom score between the two groups(P>0.05); after nursing intervention, the clinical symptom score of the study group was significantly lower than that of the control group (P < 0.05); the nursing skill score, humanistic care score and nursing attitude score of the study group were higher than those of the control group (P<0.05); the complication rate of the study group was significantly lower than that of the control group(P<0.05). Conclusion: Mecobalamin treatment of diabetic peripheral neuropathy can effectively improve the clinical symptoms of patients, supplemented by comprehensive nursing intervention, can effectively improve the medical satisfaction of patients, improve the quality of life of patients. [Key words] Mecobalamin; Diabetes Mellitus; Peripheral Neuropathy; Nursing Intervention; Nursing Effect
药物与临床 Drugs and Clinic
甲钴胺治疗糖尿病末梢神经病变的疗效观察及护理干预
邱金玉
江西省信丰县人民医院，江西 赣州 ３４１６００
[摘要] 目的：探讨甲钴胺治疗糖尿病末梢神经病变的疗效观察及护理干预。方法：５８例糖尿病末梢神经病变患者随机分为两组，两组患者
均给予组实施综合性护理干预，对比两组疗效及护理效果差异。结果：研究